Teva Remains Neutral On Erosion Worries After Sandoz Remarks

Teva’s Outlook On Price Erosion Differs From Sandoz In Solid Q1

Business decline
TEVA CEO SCHULTZ: 'NO BIG CHANGES' ON PRICE EROSION FORECASTS • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Generics

More from Products